{
  "context": "{\n### Definitions:\n- **Novel Therapeutic Approaches**: Innovative strategies or treatments designed to address specific medical conditions, particularly those that are typically resistant to established therapies.\n- **Interleukin-17 (IL-17) pathways in autoimmune disorders**: Complex signaling networks involving IL-17, a pro-inflammatory cytokine, that play a significant role in the pathogenesis of autoimmune diseases by promoting inflammatory responses and attracting immune cells.\n- **IL17A and IL17F genes**: Genes that encode for the IL-17A and IL-17F cytokines, which are crucial mediators in the immune response and are implicated in various autoimmune conditions.\n- **Epigenetic modifications impacting histone acetylation**: Chemical changes to DNA and histone proteins that affect gene expression without altering the genetic code, particularly through the addition or removal of acetyl groups on histones, influencing chromatin structure and accessibility.\n- **MicroRNAs (miRNAs) associated with immune response regulation**: Small non-coding RNA molecules that play a key role in regulating gene expression by binding to target messenger RNAs (mRNAs) and can modulate immune responses.\n- **Transcription factors involved in immune cell differentiation**: Proteins that regulate the transcription of specific genes, playing critical roles in directing the development and function of various immune cell types.\n- **Cytokine signaling pathways crucial for rheumatologic conditions**: Signaling pathways mediated by cytokines that are essential for the regulation of immune responses and the maintenance of inflammation in rheumatologic disorders.\n- **NF-kB pathway, contributing to inflammation in rheumatoid arthritis**: A critical signaling pathway activated by various stimuli, leading to the expression of genes involved in inflammation, immune response, and cell survival, notably implicated in the chronic inflammation seen in rheumatoid arthritis.\n\n### Relationships\n- **Novel Therapeutic Approaches shown to modulate Interleukin-17 (IL-17) pathways in autoimmune disorders**: This relationship indicates that the innovative treatments have the capability to affect IL-17 signaling mechanisms, which can subsequently alter immune responses and potentially improve outcomes in autoimmune disorders.\n  \n- **Interleukin-17 (IL-17) pathways in autoimmune disorders influenced by genetic variations in IL17A and IL17F genes**: This relationship suggests that genetic differences in the IL17A and IL17F genes can impact how IL-17 pathways function, possibly contributing to variability in disease susceptibility or response to treatment in individuals with autoimmune disorders.\n\n- **IL17A and IL17F genes expression regulated by epigenetic modifications impacting histone acetylation**: Indicates that the expression levels of these critical genes are controlled through epigenetic mechanisms, particularly the acetylation of histones, which can enhance or repress their transcription based on the cellular context.\n\n- **Epigenetic modifications impacting histone acetylation can be influenced by the activity of microRNAs (miRNAs) associated with immune response regulation**: This highlights a regulatory feedback loop where miRNAs can affect histone modifications, thereby influencing gene expression and ultimately impacting immune responses in various contexts.\n\n- **MicroRNAs (miRNAs) associated with immune response regulation target specific transcription factors involved in immune cell differentiation**: This connection shows that miRNAs can precisely regulate the expression of transcription factors, which are pivotal in directing the maturation and function of immune cells, thereby shaping immune responses.\n\n- **Transcription factors involved in immune cell differentiation interact with cytokine signaling pathways crucial for rheumatologic conditions**: This indicates a close interplay between transcription factors and signaling pathways driven by cytokines that are significant in the pathophysiology of rheumatologic disorders. These interactions can determine the fate and function of immune cells.\n\n- **Cytokine signaling pathways crucial for rheumatologic conditions modulated by oxidative stress through the activation of NF-kB pathway, contributing to inflammation in rheumatoid arthritis**: This relationship underscores how oxidative stress can affect cytokine signaling and amplify inflammatory responses through NF-kB activation, which plays a vital role in the advancement of rheumatoid arthritis pathology.\n}",
  "subgraph": "(`Novel Therapeutic Approaches`)-[:`shown to modulate`]->(`Interleukin-17 (IL-17) pathways in autoimmune disorders`),\n(`Interleukin-17 (IL-17) pathways in autoimmune disorders`)-[:`influenced by genetic variations in`]->(`IL17A and IL17F genes`),\n(`IL17A and IL17F genes`)-[:`expression regulated by`]->(`epigenetic modifications impacting histone acetylation`),\n(`epigenetic modifications impacting histone acetylation`)-[:`can be influenced by the activity of`]->(`microRNAs (miRNAs) associated with immune response regulation`),\n(`microRNAs (miRNAs) associated with immune response regulation`)-[:`target specific`]->(`transcription factors involved in immune cell differentiation`),\n(`transcription factors involved in immune cell differentiation`)-[:`interact with`]->(`cytokine signaling pathways crucial for rheumatologic conditions`),\n(`cytokine signaling pathways crucial for rheumatologic conditions`)-[:`modulated by oxidative stress through the activation of`]->(`NF-kB pathway, contributing to inflammation in rheumatoid arthritis`)"
}